Minerva Neurosciences Inc

NASDAQ:NERV  
1.68
+0.04 (+2.44%)
4:04:13 PM EDT: $1.73 +0.05 (+2.98%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Minerva Neurosciences Inc Stock, NASDAQ:NERV

1500 District Avenue, Suite 286, Burlington, Massachusetts 01803
United States of America
Phone: +1.617.600.7373
Number of Employees: 8
http://www.minervaneurosciences.com

Description

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson�s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.